A blood test for high-sensitivity troponin T (hsTnT) used in emergency departments successfully ruled out myocardial infarction (MI) and helped identify patients at low 30-day risk for adverse cardiac events, researchers reported in JAMA Cardiology.

A Swedish study of nearly 5,000 patients has proven the efficacy of death receptors as markers for type 2 diabetes and cardiovascular disease, according to research published in EBioMedicine.

Results from a recently published study suggest blood pressure begins to decline up to 18 years before death, with the sharpest dip occurring in the final two years.

New technology developed at New York’s Binghamton University could change the way clinicians detect heart disease with MRI scans, research published in the journal Colloid and Surfaces B: Biointerfaces suggests.

Hispanic heart patients born abroad face a greater risk of dying from cardiovascular disease than their American-born counterparts, according to new research published in the Journal of the American Heart Association.